Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-320,246
Closed -$522K 3897
2023
Q4
$522K Buy
320,246
+156,296
+95% +$268K ﹤0.01% 3189
2023
Q3
$489K Buy
163,950
+7,343
+5% +$28K ﹤0.01% 3214
2023
Q2
$698K Buy
156,607
+92,612
+145% +$415K ﹤0.01% 3069
2023
Q1
$124K Buy
63,995
+9,486
+17% +$20.5K ﹤0.01% 3689
2022
Q4
$169K Sell
54,509
-215,366
-80% -$548K ﹤0.01% 3735
2022
Q3
$712K Buy
269,875
+159,887
+145% +$360K ﹤0.01% 3060
2022
Q2
$159K Sell
109,988
-116,622
-51% -$177K ﹤0.01% 3790
2022
Q1
$415K Buy
226,610
+67,214
+42% +$209K ﹤0.01% 3486
2021
Q4
$759K Buy
+159,396
New +$641K ﹤0.01% 3206

Other funds holding IFRX

Invesco's IFRX Position: Q1 2024 in Review

Invesco sold out of InflaRx (IFRX) in Q1 2024, closing a stake of 320,246 shares — an estimated $522K sold.

Invesco first reported a position in IFRX in Q4 2021 and held it in 9 quarters. The position peaked at $759K in Q4 2021. 37 funds tracked by Wall St. Rank hold IFRX as of Q1 2024.

  • Invesco reported no remaining InflaRx position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 320,246 InflaRx shares in Q1 2024, an estimated $522K.
  • Invesco first reported a position in InflaRx in Q4 2021 and held it in 9 quarters.
  • Invesco's InflaRx position peaked at $759K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held InflaRx as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.